文献速递产科

妊娠相关子宫肌层血供增强的临床与超声特征:前瞻性队列研究

Clinical and ultrasonographic characteristics of pregnancy-related enhanced myometrial vascularity: prospective cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-04-05

终止妊娠与非存活妊娠相比(OR 3.67,95%CI 1.16-11.56,P=0.026)及经产妇与未产妇女相比(OR 2.95,95%CI 1.45-6.01,P=0.002)EMV风险增加。96%(45/47)的EMV在术后7-16周内自发消退。

要点

  • 早孕期终止妊娠或非存活妊娠管理后5-6周EMV总体发生率为35%(58/164)。
  • 终止妊娠(OR 3.67,95%CI 1.16-11.56)和经产(OR 2.95,95%CI 1.45-6.01)是EMV的危险因素。
  • 96%(45/47)的EMV在术后7-16周内自发消退,期待管理可行。

核心结论

  • EMV是早孕期终止妊娠或非存活妊娠管理后5-6周常见的一过性发现,终止妊娠和经产是危险因素,期待管理可使绝大多数病例在2-4个月内无并发症自发消退。

主要发现

  • 305名终止妊娠女性中132名参加随访,52例诊断EMV;96名非存活妊娠管理女性中32名参加随访,6例诊断EMV。
  • 终止妊娠后EMV患病率介于52/305(17%)至52/132(39%)之间,非存活妊娠管理后介于6/96(6%)至6/32(19%)之间。
  • 超声特征:所有EMV病例可见丰富迂曲肌层血管高速血流突向内膜,97%内膜不均匀异质(其中67%含囊性区),98%内膜中线消失,97%结合带异常(64%中断,33%不规则)。
  • EMV女性93%接受药物管理终止妊娠或非存活妊娠,高于无EMV女性的77%(P=0.023)。

关键数值与推荐

  • EMV超声诊断标准:异常迂曲肌层血管结构伴高速血流突向内膜,结合带异常、内膜中线消失和内膜异质支持诊断。
  • 多因素回归显示终止妊娠与非存活妊娠相比EMV风险增加(OR 3.67,95%CI 1.16-11.56,P=0.026),经产与未产相比风险增加(OR 2.95,95%CI 1.45-6.01,P=0.002)。

临床怎么用

  • 所有EMV女性接受期待管理,计划每2周超声随访直至病变消退。
  • 47例继续随访的EMV中45例(96%)在术后7-16周内自发消退,2例因盆腔不适选择手术,组织学显示新生血管混合残留绒毛膜绒毛。

局限性

  • 11名EMV女性未返回后续随访且未到门诊或急诊就诊,失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the ultrasonographic, epidemiological, clinical and evolutive characteristics of enhanced myometrial vascularity (EMV) following a first-trimester termination of pregnancy (TOP) or management of non-viable pregnancy. METHODS: This prospective study included women who underwent follow-up ultrasound examination 5-6 weeks after a first-trimester TOP or after management of a first-trimester non-viable pregnancy at the University Hospital Polyclinic San Martino of Genoa between March 2021 and March 2022. EMV was characterized using two- and three-dimensional ultrasound and Virtual Organ Computer-aided Analysis. Ultrasonographic diagnosis of EMV was made when an unusual, tortuous myometrial vessel structure, with high-velocity blood flow, protruding towards the endometrium was observed, while an abnormal junctional zone, absent endometrial midline and heterogeneous endometrium supported the diagnosis. Patients with EMV underwent expectant management with planned ultrasonographic follow-up every 2 weeks until resolution. RESULTS: During the study period, 305 women underwent TOP, of whom 132 attended the initial follow-up 5-6 weeks later, at which 52 were diagnosed with EMV. Ninety-six women were managed for a non-viable pregnancy, of whom 32 presented for follow-up, at which six had a diagnosis of EMV. Thus, overall, 164 of 401 women were included in the study and EMV was identified in 58 (35%) of these. The prevalence of EMV 5-6 weeks after a TOP was therefore between 52/305 (17%) and 52/132 (39%), and that after management of a non-viable pregnancy was between 6/96 (6%) and 6/32 (19%). Bleeding/pelvic pain was present in half (29/58) of the women with EMV, and serum human chorionic gonadotropin was detectable in 29% (17/58) at the first follow-up examination. At ultrasound assessment, all cases with EMV presented abundant tortuous myometrial vessels with high-velocity flow projecting from the myometrium towards the endometrium, along with non-uniform heterogeneous endometrium in 97% of cases, which often (67% of these) contained cystic areas, absence of the endometrial midline in 98% of cases and an abnormal junctional zone in 97% of cases (64% interrupted, 33% irregular). Most (67%) women with EMV were parous and 90% of them had undergone TOP rather than management for a non-viable pregnancy. Medical management of the TOP or non-viable pregnancy was more frequent in women with than those without EMV (93% vs 77%, P = 0.023). Multiple regression analysis showed the risk of EMV to be increased following TOP vs non-viable pregnancy (odds ratio (OR), 3.67 (95% CI, 1.16-11.56), P = 0.026) and in parous compared with nulliparous women (OR, 2.95 (95% CI, 1.45-6.01), P = 0.002). All women with EMV underwent expectant management. Eleven women did not return for subsequent follow-up examinations and did not present to our outpatient or emergency facilities, so were lost to further follow-up. Spontaneous resolution of the lesion was observed within 7-16 weeks after the procedure in 96% (45/47) of the remaining cases. Two women chose to undergo surgery for pelvic discomfort, and histology showed the presence of neovessels mixed with retained chorionic villi. CONCLUSIONS: EMV is a transient and common finding 5-6 weeks following first-trimester TOP or management of non-viable pregnancy. TOP and being parous are risk factors for EMV. Expectant management of EMV is appropriate, because, in almost all cases, this resolves spontaneously, without complications, within 2-4 months. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Xholli A, Scovazzi U, Londero AP, et al. Clinical and ultrasonographic characteristics of pregnancy-related enhanced myometrial vascularity: prospective cohort study. Ultrasound Obstet Gynecol. 2024. PMID: 37984401. doi:10.1002/uog.27537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。